Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Gemphire Therapeutics Inc.

TRADE

NASDAQ: GEMPHealthcare / Biotechnology / USA
1.64-0.05-2.96%Vol 84 7451Y Perf -83.06%
Oct 17th, 2018 16:00
BID1.63 ASK1.66
Open1.69 Previous Close1.69
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.00 
Analyst Rating
Moderate Buy 2.33
Potencial %
21.95 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)23 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
7.64 
Earnings Date
12th Nov 2018

Today's Price Range

1.591.75

 

52wk Range

0.8311.43

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-27.11%
3 Months
-79.13%
6 Months
-73.51%
1 Year
-83.06%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
GEMP1.64-0.0500-2.96
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.50
Current Ratio 4.60
Long Term Debt to Total Capital 0.33
Total Debt to Equity 0.50
Interest Coverage -
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.31
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.70
Cash Flow Per Share -2.30
Price to Tangible Book1.31
Book Value per Share1.05
Enterprise Value (in ths.)1 839
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -178.89
Return on Assets (5Y Avg) -
ROA last 12 Months -113.18
Return on Capital (5Y Avg) -
ROC last 12 Months -110.30
Return on invested Capital Q -23.78
Return on invested Capital Y-149.68
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.51-0.477.84
Q01 2018-0.59-0.581.69
Q04 2017-0.72-0.6312.50
Q03 2017-0.72-0.82-13.89
Q02 2017-0.80-0.747.50
Q01 2017-0.61-0.79-29.51
Q04 2016--0.78-
Q03 2016-0.28-0.56-100.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.4440.54Positive
12/2018 QR-0.3945.07Positive
12/2018 FY-1.8826.85Positive
12/2019 FY-2.0521.76Positive
Next Report Date12th Nov 2018
Estimated EPS Next Report-0.44
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume84 745
Shares Outstanding (in ths.)14 270
Trades Count203
Dollar Volume136 796
Avg. Volume476 516
Avg. Weekly Volume173 367
Avg. Monthly Volume290 697
Avg. Quarterly Volume958 119

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

41%59%

Bearish Bullish

57%43%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (25.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (25.00 %)
Hold
2 (66.67 %)
3 (75.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.50
Strong Buy
1.25

There are no comments yet.

News

x